Concepts (307)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Menopause | 69 | 2025 | 249 | 15.430 |
Why?
|
| Hot Flashes | 38 | 2025 | 94 | 10.940 |
Why?
|
| Cross-Cultural Comparison | 15 | 2013 | 43 | 2.470 |
Why?
|
| Biological Evolution | 4 | 2025 | 114 | 2.290 |
Why?
|
| Exercise | 9 | 2025 | 883 | 1.960 |
Why?
|
| Female | 98 | 2025 | 30695 | 1.810 |
Why?
|
| Middle Aged | 68 | 2025 | 16310 | 1.570 |
Why?
|
| Women's Health | 14 | 2022 | 360 | 1.510 |
Why?
|
| Sleep | 3 | 2024 | 215 | 1.470 |
Why?
|
| Humans | 99 | 2025 | 59282 | 1.250 |
Why?
|
| Self Report | 6 | 2024 | 359 | 1.240 |
Why?
|
| Hydrocortisone | 3 | 2024 | 187 | 1.110 |
Why?
|
| Cross-Sectional Studies | 20 | 2024 | 2373 | 1.100 |
Why?
|
| Stress, Psychological | 5 | 2024 | 442 | 1.070 |
Why?
|
| Mexico | 14 | 2022 | 36 | 1.070 |
Why?
|
| Adult | 52 | 2025 | 15663 | 1.020 |
Why?
|
| Sterilization, Tubal | 4 | 2021 | 10 | 0.960 |
Why?
|
| Progesterone | 2 | 2023 | 158 | 0.950 |
Why?
|
| Quality of Life | 3 | 2022 | 1137 | 0.940 |
Why?
|
| Cardiovascular Diseases | 5 | 2025 | 788 | 0.930 |
Why?
|
| Parity | 7 | 2023 | 70 | 0.920 |
Why?
|
| Anti-Mullerian Hormone | 6 | 2022 | 62 | 0.920 |
Why?
|
| Cold Temperature | 1 | 2024 | 51 | 0.910 |
Why?
|
| Emigrants and Immigrants | 5 | 2024 | 33 | 0.900 |
Why?
|
| Surveys and Questionnaires | 26 | 2024 | 2511 | 0.900 |
Why?
|
| Psychological Tests | 1 | 2024 | 45 | 0.880 |
Why?
|
| Estradiol | 4 | 2023 | 247 | 0.870 |
Why?
|
| Lignans | 1 | 2023 | 15 | 0.870 |
Why?
|
| Isoflavones | 1 | 2023 | 16 | 0.860 |
Why?
|
| Nails | 1 | 2024 | 38 | 0.860 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 111 | 0.840 |
Why?
|
| Estrogen Replacement Therapy | 5 | 2019 | 77 | 0.840 |
Why?
|
| Obesity | 5 | 2024 | 1166 | 0.810 |
Why?
|
| Hand Strength | 1 | 2022 | 28 | 0.800 |
Why?
|
| Urinary Incontinence | 1 | 2022 | 40 | 0.790 |
Why?
|
| Sweating | 7 | 2024 | 26 | 0.780 |
Why?
|
| Social Support | 2 | 2024 | 355 | 0.760 |
Why?
|
| Sleep Wake Disorders | 1 | 2022 | 65 | 0.750 |
Why?
|
| Epidemiologic Methods | 5 | 2011 | 65 | 0.740 |
Why?
|
| Age Factors | 14 | 2024 | 1504 | 0.730 |
Why?
|
| Rural Population | 2 | 2021 | 185 | 0.690 |
Why?
|
| Pain | 5 | 2024 | 396 | 0.690 |
Why?
|
| Postpartum Period | 3 | 2024 | 182 | 0.670 |
Why?
|
| Hysterectomy | 3 | 2013 | 65 | 0.630 |
Why?
|
| Depression | 5 | 2020 | 828 | 0.630 |
Why?
|
| Menarche | 4 | 2023 | 35 | 0.620 |
Why?
|
| Bangladesh | 8 | 2024 | 18 | 0.620 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2015 | 21 | 0.590 |
Why?
|
| Galvanic Skin Response | 6 | 2015 | 23 | 0.580 |
Why?
|
| Aging | 8 | 2016 | 710 | 0.570 |
Why?
|
| Life Style | 9 | 2024 | 299 | 0.550 |
Why?
|
| Culture | 2 | 2014 | 73 | 0.550 |
Why?
|
| Attitude to Health | 6 | 2013 | 279 | 0.520 |
Why?
|
| Hormone Replacement Therapy | 2 | 2008 | 28 | 0.500 |
Why?
|
| London | 6 | 2024 | 12 | 0.500 |
Why?
|
| Temperature | 5 | 2024 | 295 | 0.500 |
Why?
|
| Pregnancy | 10 | 2024 | 2202 | 0.500 |
Why?
|
| Symptom Assessment | 1 | 2015 | 43 | 0.480 |
Why?
|
| Premenstrual Syndrome | 2 | 2016 | 96 | 0.480 |
Why?
|
| Massachusetts | 10 | 2024 | 2003 | 0.470 |
Why?
|
| Anthropology | 1 | 2014 | 3 | 0.470 |
Why?
|
| Menopause, Premature | 3 | 2023 | 25 | 0.470 |
Why?
|
| Logistic Models | 10 | 2023 | 1232 | 0.460 |
Why?
|
| Hawaii | 10 | 2013 | 22 | 0.460 |
Why?
|
| Metabolic Syndrome | 2 | 2024 | 131 | 0.460 |
Why?
|
| Health Status | 6 | 2013 | 424 | 0.430 |
Why?
|
| Body Mass Index | 8 | 2024 | 831 | 0.430 |
Why?
|
| Socioeconomic Factors | 8 | 2017 | 741 | 0.430 |
Why?
|
| Employment | 1 | 2014 | 123 | 0.410 |
Why?
|
| Breast Feeding | 3 | 2021 | 143 | 0.400 |
Why?
|
| Postmenopause | 1 | 2014 | 224 | 0.400 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 149 | 0.400 |
Why?
|
| Smoking | 7 | 2019 | 826 | 0.370 |
Why?
|
| Risk Factors | 10 | 2024 | 4982 | 0.360 |
Why?
|
| Educational Status | 7 | 2019 | 264 | 0.350 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2008 | 687 | 0.340 |
Why?
|
| Periodicity | 1 | 2010 | 49 | 0.340 |
Why?
|
| Decision Making | 2 | 2011 | 394 | 0.340 |
Why?
|
| Menstrual Cycle | 3 | 2016 | 81 | 0.320 |
Why?
|
| Personal Satisfaction | 1 | 2009 | 76 | 0.320 |
Why?
|
| Adiposity | 2 | 2022 | 74 | 0.320 |
Why?
|
| Resilience, Psychological | 1 | 2009 | 55 | 0.310 |
Why?
|
| Urban Population | 2 | 2017 | 179 | 0.300 |
Why?
|
| Hinduism | 2 | 2024 | 3 | 0.300 |
Why?
|
| Islam | 2 | 2024 | 5 | 0.300 |
Why?
|
| Spain | 5 | 2013 | 32 | 0.300 |
Why?
|
| Marital Status | 2 | 2013 | 43 | 0.290 |
Why?
|
| Urban Health Services | 1 | 2008 | 14 | 0.290 |
Why?
|
| Adolescent | 14 | 2022 | 5822 | 0.290 |
Why?
|
| Circadian Rhythm | 2 | 2010 | 373 | 0.280 |
Why?
|
| Dyspnea | 2 | 2022 | 116 | 0.280 |
Why?
|
| Longitudinal Studies | 5 | 2024 | 1189 | 0.280 |
Why?
|
| Premenopause | 3 | 2022 | 55 | 0.280 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2016 | 82 | 0.270 |
Why?
|
| Blood Pressure | 4 | 2016 | 495 | 0.270 |
Why?
|
| Mental Health | 2 | 2024 | 335 | 0.260 |
Why?
|
| India | 2 | 2024 | 150 | 0.260 |
Why?
|
| Perimenopause | 2 | 2025 | 31 | 0.260 |
Why?
|
| Pilot Projects | 3 | 2021 | 914 | 0.260 |
Why?
|
| Interviews as Topic | 5 | 2013 | 481 | 0.260 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 1118 | 0.250 |
Why?
|
| Ovulation Detection | 1 | 2005 | 4 | 0.250 |
Why?
|
| Morocco | 3 | 2012 | 3 | 0.240 |
Why?
|
| Lebanon | 3 | 2012 | 10 | 0.240 |
Why?
|
| Ovulation | 1 | 2005 | 28 | 0.240 |
Why?
|
| Age Distribution | 5 | 2013 | 249 | 0.240 |
Why?
|
| Guidelines as Topic | 5 | 2011 | 153 | 0.240 |
Why?
|
| Brachial Artery | 1 | 2025 | 28 | 0.240 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 98 | 0.240 |
Why?
|
| Heterosexuality | 1 | 2024 | 9 | 0.240 |
Why?
|
| Vasodilation | 1 | 2025 | 35 | 0.240 |
Why?
|
| Mental Recall | 1 | 2005 | 88 | 0.230 |
Why?
|
| Contraceptives, Oral | 2 | 2021 | 22 | 0.230 |
Why?
|
| Environment | 2 | 2015 | 119 | 0.230 |
Why?
|
| Humidity | 1 | 2024 | 11 | 0.230 |
Why?
|
| Proportional Hazards Models | 4 | 2024 | 674 | 0.230 |
Why?
|
| Qatar | 1 | 2024 | 1 | 0.230 |
Why?
|
| Musculoskeletal Diseases | 1 | 2005 | 101 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2007 | 724 | 0.220 |
Why?
|
| Phytoestrogens | 1 | 2023 | 9 | 0.220 |
Why?
|
| Child, Preschool | 4 | 2023 | 1782 | 0.220 |
Why?
|
| Aged | 15 | 2019 | 13412 | 0.220 |
Why?
|
| Insulin Resistance | 2 | 2024 | 392 | 0.220 |
Why?
|
| Actigraphy | 1 | 2024 | 47 | 0.220 |
Why?
|
| Adipose Tissue | 2 | 2024 | 283 | 0.210 |
Why?
|
| Information Services | 1 | 2003 | 34 | 0.210 |
Why?
|
| Fertility | 1 | 2023 | 78 | 0.210 |
Why?
|
| Longevity | 2 | 2020 | 110 | 0.210 |
Why?
|
| Follicular Atresia | 2 | 2021 | 3 | 0.200 |
Why?
|
| Health Surveys | 5 | 2015 | 298 | 0.200 |
Why?
|
| Education, Medical, Continuing | 1 | 2003 | 95 | 0.200 |
Why?
|
| Testosterone | 1 | 2023 | 112 | 0.200 |
Why?
|
| Analysis of Variance | 6 | 2013 | 589 | 0.200 |
Why?
|
| Child | 5 | 2024 | 4173 | 0.200 |
Why?
|
| Body Height | 1 | 2022 | 68 | 0.200 |
Why?
|
| Overweight | 1 | 2024 | 238 | 0.200 |
Why?
|
| Headache | 2 | 2012 | 54 | 0.190 |
Why?
|
| Mongolia | 1 | 2021 | 1 | 0.190 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 49 | 0.190 |
Why?
|
| Drug Utilization | 1 | 2003 | 208 | 0.190 |
Why?
|
| Cultural Characteristics | 3 | 2007 | 35 | 0.190 |
Why?
|
| Marriage | 1 | 2001 | 23 | 0.190 |
Why?
|
| Health Behavior | 3 | 2014 | 451 | 0.190 |
Why?
|
| Population Surveillance | 2 | 2007 | 194 | 0.190 |
Why?
|
| Diabetes, Gestational | 1 | 2023 | 138 | 0.190 |
Why?
|
| Health Status Indicators | 1 | 2001 | 92 | 0.180 |
Why?
|
| Fatigue | 2 | 2012 | 103 | 0.180 |
Why?
|
| Vascular Diseases | 2 | 2011 | 75 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2022 | 151 | 0.170 |
Why?
|
| Prospective Studies | 7 | 2022 | 3065 | 0.170 |
Why?
|
| Body Temperature Regulation | 2 | 2013 | 20 | 0.170 |
Why?
|
| Animals | 3 | 2025 | 19601 | 0.170 |
Why?
|
| Young Adult | 6 | 2024 | 4266 | 0.160 |
Why?
|
| Ovarian Diseases | 1 | 2018 | 19 | 0.160 |
Why?
|
| Self Concept | 2 | 2013 | 105 | 0.150 |
Why?
|
| Indians, North American | 1 | 2018 | 27 | 0.150 |
Why?
|
| Cohort Studies | 5 | 2023 | 2372 | 0.150 |
Why?
|
| Emigration and Immigration | 2 | 2015 | 25 | 0.150 |
Why?
|
| Weight Gain | 2 | 2022 | 163 | 0.140 |
Why?
|
| Monitoring, Ambulatory | 3 | 2013 | 56 | 0.130 |
Why?
|
| Contraception | 2 | 2021 | 67 | 0.130 |
Why?
|
| Odds Ratio | 2 | 2023 | 745 | 0.130 |
Why?
|
| Saliva | 1 | 2016 | 99 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 30 | 0.130 |
Why?
|
| Infant | 3 | 2015 | 1486 | 0.130 |
Why?
|
| Ovarian Reserve | 1 | 2015 | 8 | 0.130 |
Why?
|
| Reproductive Health | 1 | 2015 | 24 | 0.120 |
Why?
|
| Contraindications | 1 | 2015 | 46 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 53 | 0.120 |
Why?
|
| Infant Care | 1 | 2015 | 18 | 0.120 |
Why?
|
| Body Temperature | 1 | 2015 | 45 | 0.120 |
Why?
|
| Neanderthals | 1 | 2014 | 2 | 0.120 |
Why?
|
| Ovary | 1 | 2014 | 98 | 0.110 |
Why?
|
| Infant, Newborn | 2 | 2015 | 1283 | 0.110 |
Why?
|
| Motor Activity | 2 | 2008 | 333 | 0.110 |
Why?
|
| Self Care | 2 | 2007 | 207 | 0.110 |
Why?
|
| Attitude | 1 | 2014 | 96 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2018 | 541 | 0.110 |
Why?
|
| Europe | 2 | 2018 | 184 | 0.100 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2010 | 35 | 0.100 |
Why?
|
| Japan | 3 | 2009 | 51 | 0.100 |
Why?
|
| Time Factors | 4 | 2024 | 3614 | 0.100 |
Why?
|
| Hypertension | 3 | 2016 | 567 | 0.100 |
Why?
|
| Activities of Daily Living | 2 | 2011 | 289 | 0.100 |
Why?
|
| Mastodynia | 1 | 2012 | 3 | 0.100 |
Why?
|
| United States | 5 | 2020 | 7385 | 0.100 |
Why?
|
| Irritable Mood | 1 | 2012 | 16 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2014 | 357 | 0.100 |
Why?
|
| Biomarkers | 3 | 2024 | 1305 | 0.100 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 98 | 0.100 |
Why?
|
| Back Pain | 1 | 2012 | 48 | 0.100 |
Why?
|
| Anxiety | 2 | 2012 | 387 | 0.100 |
Why?
|
| Reproduction | 2 | 2023 | 89 | 0.090 |
Why?
|
| Hypesthesia | 1 | 2011 | 8 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 241 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2012 | 94 | 0.090 |
Why?
|
| Dizziness | 1 | 2011 | 16 | 0.090 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2011 | 12 | 0.090 |
Why?
|
| Arthralgia | 1 | 2012 | 55 | 0.090 |
Why?
|
| Chest Pain | 1 | 2012 | 81 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 69 | 0.090 |
Why?
|
| Age of Onset | 2 | 2018 | 170 | 0.090 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2011 | 35 | 0.090 |
Why?
|
| Mammography | 2 | 2015 | 269 | 0.090 |
Why?
|
| Menstruation | 1 | 2010 | 31 | 0.090 |
Why?
|
| Self Medication | 2 | 2007 | 14 | 0.090 |
Why?
|
| World War II | 1 | 2009 | 1 | 0.080 |
Why?
|
| Linear Models | 3 | 2015 | 402 | 0.080 |
Why?
|
| Germany | 1 | 2009 | 52 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 409 | 0.080 |
Why?
|
| Male | 5 | 2023 | 27727 | 0.080 |
Why?
|
| Observational Studies as Topic | 2 | 2019 | 55 | 0.080 |
Why?
|
| Random Allocation | 1 | 2008 | 192 | 0.070 |
Why?
|
| Endometrium | 1 | 2008 | 28 | 0.070 |
Why?
|
| Breast | 2 | 2022 | 173 | 0.070 |
Why?
|
| Specialization | 1 | 2008 | 74 | 0.070 |
Why?
|
| Medicine | 1 | 2008 | 56 | 0.070 |
Why?
|
| Bone Density | 1 | 2008 | 129 | 0.070 |
Why?
|
| Life Change Events | 1 | 2007 | 65 | 0.070 |
Why?
|
| Education | 1 | 2007 | 67 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2008 | 271 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 364 | 0.070 |
Why?
|
| Biopsy | 1 | 2008 | 411 | 0.060 |
Why?
|
| Prevalence | 3 | 2020 | 1252 | 0.060 |
Why?
|
| Climate | 1 | 2005 | 4 | 0.060 |
Why?
|
| Workplace | 1 | 2007 | 169 | 0.060 |
Why?
|
| Sexual Behavior | 2 | 2011 | 189 | 0.060 |
Why?
|
| Ovulation Prediction | 1 | 2005 | 2 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 5128 | 0.060 |
Why?
|
| Seasons | 1 | 2005 | 123 | 0.060 |
Why?
|
| Bisexuality | 1 | 2024 | 14 | 0.060 |
Why?
|
| Homosexuality, Female | 1 | 2024 | 21 | 0.060 |
Why?
|
| Incidence | 2 | 2019 | 1236 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2008 | 396 | 0.060 |
Why?
|
| Slovenia | 1 | 2004 | 3 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2011 | 717 | 0.060 |
Why?
|
| Altitude | 1 | 2004 | 14 | 0.060 |
Why?
|
| Latin America | 2 | 2013 | 12 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2007 | 716 | 0.050 |
Why?
|
| Hormones | 2 | 2015 | 60 | 0.050 |
Why?
|
| Nurses | 1 | 2024 | 102 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2006 | 288 | 0.050 |
Why?
|
| Sexual and Gender Minorities | 1 | 2024 | 70 | 0.050 |
Why?
|
| Gynecology | 1 | 2003 | 49 | 0.050 |
Why?
|
| Sternum | 1 | 2002 | 27 | 0.050 |
Why?
|
| Minority Groups | 1 | 2024 | 135 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2019 | 1920 | 0.050 |
Why?
|
| Heart Rate | 1 | 2004 | 307 | 0.050 |
Why?
|
| Research Design | 1 | 2005 | 555 | 0.050 |
Why?
|
| Estrogens | 1 | 2002 | 109 | 0.050 |
Why?
|
| Sex Attractants | 1 | 2001 | 1 | 0.050 |
Why?
|
| Birth Weight | 1 | 2022 | 81 | 0.050 |
Why?
|
| Divorce | 1 | 2001 | 2 | 0.050 |
Why?
|
| Widowhood | 1 | 2001 | 4 | 0.050 |
Why?
|
| Single Person | 1 | 2001 | 4 | 0.050 |
Why?
|
| Developed Countries | 1 | 2001 | 16 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 69 | 0.050 |
Why?
|
| New York | 1 | 2001 | 134 | 0.050 |
Why?
|
| Qualitative Research | 2 | 2017 | 618 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2023 | 461 | 0.050 |
Why?
|
| Developing Countries | 1 | 2001 | 85 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 445 | 0.040 |
Why?
|
| Forecasting | 1 | 2001 | 219 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2012 | 485 | 0.040 |
Why?
|
| Income | 1 | 2001 | 156 | 0.040 |
Why?
|
| Mortality | 1 | 2001 | 155 | 0.040 |
Why?
|
| Insulin | 1 | 2023 | 674 | 0.040 |
Why?
|
| Australia | 1 | 2018 | 86 | 0.040 |
Why?
|
| Models, Biological | 1 | 2004 | 1140 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2019 | 244 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 1561 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 37 | 0.030 |
Why?
|
| Inhibins | 1 | 2016 | 50 | 0.030 |
Why?
|
| Adolescent Development | 1 | 2015 | 15 | 0.030 |
Why?
|
| Self Administration | 2 | 2007 | 46 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 364 | 0.030 |
Why?
|
| Breast Density | 1 | 2015 | 16 | 0.030 |
Why?
|
| Body Composition | 1 | 2016 | 146 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2007 | 244 | 0.030 |
Why?
|
| Child Development | 1 | 2015 | 79 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 902 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1051 | 0.030 |
Why?
|
| Demography | 1 | 2013 | 169 | 0.030 |
Why?
|
| Parasitic Diseases | 1 | 2012 | 6 | 0.030 |
Why?
|
| Anthropometry | 1 | 2012 | 78 | 0.030 |
Why?
|
| Diet | 1 | 2016 | 497 | 0.030 |
Why?
|
| Cyclonic Storms | 1 | 2012 | 21 | 0.020 |
Why?
|
| Migraine Disorders | 1 | 2012 | 39 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2012 | 84 | 0.020 |
Why?
|
| Libido | 1 | 2011 | 3 | 0.020 |
Why?
|
| Sexuality | 1 | 2011 | 25 | 0.020 |
Why?
|
| Research Report | 1 | 2011 | 26 | 0.020 |
Why?
|
| Acculturation | 1 | 2011 | 33 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 2337 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2011 | 134 | 0.020 |
Why?
|
| Stroke | 1 | 2019 | 1127 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 121 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2011 | 69 | 0.020 |
Why?
|
| Affect | 1 | 2010 | 123 | 0.020 |
Why?
|
| New York City | 1 | 2007 | 75 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 1998 | 6071 | 0.020 |
Why?
|
| Systole | 1 | 2007 | 109 | 0.020 |
Why?
|
| Philippines | 1 | 2004 | 5 | 0.010 |
Why?
|
| Uganda | 1 | 2004 | 33 | 0.010 |
Why?
|
| Faculty | 1 | 2001 | 51 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 935 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 1025 | 0.010 |
Why?
|